This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser.
Print Document
View Excel Document
Cover
Cover Page
Financial Statements
Condensed Balance Sheets
Condensed Balance Sheets (Parenthetical)
Consolidated Statements of Operations and Comprehensive Loss
Consolidated Statements of Stockholders' Equity
Consolidated Statements of Stockholders' Equity (Parenthetical)
Condensed Consolidated Statements of Cash Flows
Notes to Financial Statements
Organization and Description of the Business
Summary of Significant Accounting Policies
Business Combination
Fair Value Measurement
Balance Sheet Components
Lease
Stockholder's Equity
Public and Private Warrants
Equity Plans and Related Equity Activities
Commitments and Contingencies
Income Taxes
Net Loss Per Share
401(k) Plan
Subsequent Event
Accounting Policies
Summary of Significant Accounting Policies (Policies)
Notes Tables
Business Combination (Tables)
Fair Value Measurements (Tables)
Balance Sheet Components (Tables)
Lease (Tables)
Stockholder's Equity (Tables)
Equity Plans and Related Equity Activities (Tables)
Income Taxes (Tables)
Net Loss Per Share (Tables)
Notes Details
Organization and Description of the Business - Additional Information (Detail)
Summary of Significant Accounting Policies - Additional Information (Detail)
Business Combination - Additional Information (Details)
Business Combination - Schedule of Reconciliation of Elements (Details)
Business Combination - Schedule of Number of Common Stock Issued Following the Business Combination (Details)
Business Combination - Schedule of Number of Legacy Apexigen Shares (Details)
Fair Value Measurement - Summary of Apexigen measured at fair value on a recurring basis (Detail)
Fair Value Measurement - Additional Information (Detail)
Fair Value Measurement - Summary of fair value of Apexigen's marketable securities and the gross unrealized holding gains and losses (Detail)
Balance Sheet Components - Summary Of Prepaid Expenses And Other Current Assets (Detail)
Balance Sheet Components - Summary of Property and Equipment, Net (Detail)
Balance Sheet Components - Summary of Accrued liabilities (Detail)
Balance Sheet Components - Additional Information (Detail)
Lease - Additional Information (Detail)
Lease - Summary of future minimum lease payments (Detail)
Stockholder's Equity - Additional Information (Detail)
Stockholder's Equity - Schedule of Convertible Preferred Stock (Detail)
Stockholder's Equity - Summary of Common Stock (Detail)
Public and Private Warrants - Additional Information (Details)
Clinical Study Agreement Amendment With Parker Institute - Additional Information (Detail)
Equity Plans and Related Equity Activities - Additional Information (Details)
Equity Plans and Related Equity Activities - Summary of Stock Based Compensation Expense Related To Stock Options Granted (Details)
Equity Plans and Related Equity Activities - Summary of Assumptions for Stock Options Granted and ESPP (Details)
Equity Plans and Related Equity Activities - Summary of Equity Plans' Activity (Details)
Equity Plans and Related Equity Activities - Summary of Outstanding Awards (Details)
Commitments and Contingencies - Additional Information (Detail)
Income Taxes - Additional Information (Details)
Income Taxes - Schedule of Effective Tax Rate of Provision for Income Taxes Differs From Federal Statutory Rate (Details)
Incme Taxes - Schedule of Components of Deferred Tax Assets and Liabilities (Details)
Income Taxes - Schedule of Unrecognized Tax Benefits Roll Forward (Details)
Net Loss Per Share - Summary of Diluted Net Loss Per Share for the Periods Presented Due To Their Anti-Dilutive Effect (Detail)
401(k) Plan - Additional Information (Details)
Subsequent Event Additional Information (Details)
All Reports